about
Effects of GCK, GCKR, G6PC2 and MTNR1B variants on glucose metabolism and insulin secretionLinkage disequilibrium mapping of the replicated type 2 diabetes linkage signal on chromosome 1qGenome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibilityGenome-wide association study identifies three novel loci for type 2 diabetes.Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians.A genome-wide association study identifies GRK5 and RASGRP1 as type 2 diabetes loci in Chinese Hans.The genetic architecture of type 2 diabetesAssociation analyses of East Asian individuals and trans-ancestry analyses with European individuals reveal new loci associated with cholesterol and triglyceride levels.An evaluation of the performance of HapMap SNP data in a Shanghai Chinese population: analyses of allele frequency, linkage disequilibrium pattern and tagging SNPs transferability on chromosome 1q21-q25PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese populationThe effect of glucose-dependent insulinotropic polypeptide (GIP) variants on visceral fat accumulation in Han Chinese populationsGenome-wide association meta-analysis identifies novel variants associated with fasting plasma glucose in East Asians.Circulating Unsaturated Fatty Acids Delineate the Metabolic Status of Obese Individuals.Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes.Genome-wide association study in a Chinese population identifies a susceptibility locus for type 2 diabetes at 7q32 near PAX4.Common variants of hepatocyte nuclear factor 1beta are associated with type 2 diabetes in a Chinese population.Polymorphisms of the KCNQ1 gene are associated with the therapeutic responses of sulfonylureas in Chinese patients with type 2 diabetes.Pharmacogenomics of glinides.Sodium-glucose co-transporter (SGLT) and glucose transporter (GLUT) expression in the kidney of type 2 diabetic subjects.A Low-Frequency Inactivating AKT2 Variant Enriched in the Finnish Population Is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk.Role of gut microbiota, bile acids and their cross-talk in the effects of bariatric surgery on obesity and type 2 diabetes.Genetic and clinical variables identify predictors for chronic kidney disease in type 2 diabetes.A causal relationship between uric acid and diabetic macrovascular disease in Chinese type 2 diabetes patients: A Mendelian randomization analysis.Common variants in or near ZNRF1, COLEC12, SCYL1BP1 and API5 are associated with diabetic retinopathy in Chinese patients with type 2 diabetes.Phenotypic heterogeneity in Chinese patients with hepatocyte nuclear factor-1β mutations.Association between KCNQ1 genetic variants and obesity in Chinese patients with type 2 diabetes.Variations in KCNQ1 are associated with type 2 diabetes and beta cell function in a Chinese population.Association of genetic variants of NOS1AP with type 2 diabetes in a Chinese population.Association of KCNJ11 and ABCC8 genetic polymorphisms with response to repaglinide in Chinese diabetic patients.Rapid Elevation in CMPF May Act As a Tipping Point in Diabetes Development.Effects of ABCA1 variants on rosiglitazone monotherapy in newly diagnosed type 2 diabetes patients.Whole-exome sequencing identifies a novel INS mutation causative of maturity-onset diabetes of the young 10.Diabetes in China: Epidemiology and Genetic Risk Factors and Their Clinical Utility in Personalized Medication.Mendelian randomization analysis to assess a causal effect of haptoglobin on macroangiopathy in Chinese type 2 diabetes patients.Association of serum uric acid levels with osteoporosis and bone turnover markers in a Chinese population.Association of adiposity indices with bone density and bone turnover in the Chinese population.Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits.Association of PAX4 genetic variants with oral antidiabetic drugs efficacy in Chinese type 2 diabetes patients.Overall and central obesity with insulin sensitivity and secretion in a Han Chinese population: a Mendelian randomization analysis.Impaired pancreatic beta cell compensatory function is the main cause of type 2 diabetes in individuals with high genetic risk: a 9 year prospective cohort study in the Chinese population.
P50
Q24293522-13987945-DCF0-4405-AD63-32BD9C23B97DQ28752440-D9D15CA9-10B6-408B-A955-8A310DFB46ACQ29417007-2CA0886F-95D5-4E2D-9F52-51EABF88D986Q29417014-7FAFB31F-E66E-46DC-84DE-9D5D5637030DQ29417142-8E6B55A7-4552-4E6D-BFD5-1662CD914964Q29417144-3A8A7F81-6E06-486E-A7EA-8C7B55814B2BQ29583824-160424BF-6505-47FE-A489-1DC325646E9FQ30252887-9B96716F-D06E-4A8D-97BE-51BC317CF09DQ33321350-F12A814C-C027-4561-93F6-8948AC1673F6Q33513212-66AAEE87-DFC6-495E-B154-8488CE6FD94BQ33920112-4E5064FF-4FA5-43A2-A4E3-93B5AC28F236Q34762509-D5AF684F-4BA2-4205-BE05-C55F506C8E30Q35858421-6129B6A8-75DA-4649-9E88-DEA7DE01CC96Q36536523-2B115DD4-62FF-44C2-9BA5-3B7947AF380DQ36828628-3CF581D9-6495-498F-87B8-C82CF3DE4E80Q37141735-A920BD8A-B383-4670-AF2E-C6E2A9431196Q37571899-FCC73A07-A79C-47E9-BFF3-B97AEA38328FQ38307994-9DAC4CD3-3A87-4191-AEB3-86CBA2B0A534Q38800979-A35439A6-E8B6-442D-B993-0234B07AAC5CQ38877389-7BF37CD9-4DDF-4044-9961-37D6149257DBQ39256982-7A36A629-7048-4371-B540-19140393590EQ40066068-6DE77694-A5F8-46DB-A94F-81C244746E9DQ40807571-AAB3ED25-2AA2-4C2C-8F45-C273526EA620Q41144757-814A4DF1-0E94-426C-959C-7E2A6E7B848AQ42496899-A5C37DC1-0572-41E4-BDE4-A7EED484BEF6Q43988592-99F418C7-C082-4B15-9D56-3678635697D5Q44926642-480243BD-6254-4DD9-9C1D-CF9BA2ED6DABQ44991023-C228C4A7-D545-46C2-8FE7-FB765A0D0CCEQ46457350-B6DD1D44-ABF1-4D79-BEA1-D7BAFD8B3634Q46576600-1F9304C4-BCE1-4074-B1D3-2630D04DCB5FQ46794502-910C76D7-96A3-4E43-B8EA-84FA24DA05B9Q47676972-17E4320C-9950-4F8D-B190-C4D6ADC8EB00Q47771162-65684831-98DA-4F7F-82E1-164A00948A2FQ48233021-1C2EA303-805A-4221-BF41-5693A9E62CC2Q49849977-24E92801-54EC-48BB-9C11-4FC738CC7274Q50859704-D4FCDCE0-E1B7-4B19-A5AB-E845458D77FEQ51009301-6FFBA209-B759-4246-830D-2063E54E7310Q51323776-22613CC9-F2AB-476D-BDAC-98C122F25DE3Q53772145-BB801C0B-4234-49BF-A2AC-D5948A62EE5FQ53792054-BDF5B7E4-9992-4AD7-A1EF-C2A44DC1B55E
P50
description
researcher
@en
հետազոտող
@hy
name
Cheng Hu
@ast
Cheng Hu
@en
Cheng Hu
@es
Cheng Hu
@nl
type
label
Cheng Hu
@ast
Cheng Hu
@en
Cheng Hu
@es
Cheng Hu
@nl
prefLabel
Cheng Hu
@ast
Cheng Hu
@en
Cheng Hu
@es
Cheng Hu
@nl
P106
P31
P496
0000-0003-4314-2386